Medtronic plc (MDT): EBITDA
$9.43B
Year ended 2026-04-24
$9.72B
Trailing 12 months to 2026-07-31
+4.8%
3-year compound annual growth
+5.6%
5-year compound annual growth
+1.4%
10-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2026-04-24 | $9.43B | +6.9% | 2026-06-18, From 2025-04-26 |
| 2025-04-25 | $8.82B | +13.2% | 2026-06-18, From 2024-04-27 |
| 2024-04-26 | $7.79B | -4.8% | 2026-06-18, From 2023-04-29 |
| 2023-04-28 | $8.18B | -3.3% | 2025-06-20, From 2022-04-30 |
| 2022-04-29 | $8.46B | +17.7% | 2024-06-20, From 2021-05-01 |
| 2021-04-30 | $7.19B | -3.6% | 2023-06-22, From 2020-04-25 |
| 2020-04-24 | $7.45B | -16.5% | 2022-06-23, From 2019-04-27 |
| 2019-04-26 | $8.93B | -3.8% | 2021-06-25, From 2018-04-28 |
| 2018-04-27 | $9.28B | +11.9% | 2020-06-19, From 2017-04-29 |
| 2017-04-28 | $8.30B | +1.5% | 2019-06-21, From 2016-04-30 |
| 2016-04-29 | $8.18B | n/c | 2018-06-22, From 2015-04-25 |
| 2015-04-24 | $5.07B | +8.8% | 2017-06-27, From 2014-04-26 |
| 2014-04-25 | $4.66B | -10.7% | 2016-06-28, From 2013-04-27 |
| 2013-04-26 | $5.22B | n/a | 2015-06-23, From 2012-04-28 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Medtronic plc (MDT) | 2026-04-24 | $9.43B | +6.9% |
| Integer Holdings Corp (ITGR) | 2025-12-31 | $351.93M | +10.2% |
| TransMedics Group, Inc. (TMDX) | 2025-12-31 | $135.77M | +137.1% |
| InMode Ltd. (INMD) | 2025-12-31 | $86.08M | -24.0% |
| Axogen, Inc. (AXGN) | 2025-12-31 | -$1.19M | n/m |
| Outset Medical, Inc. (OM) | 2025-12-31 | -$62.37M | n/m |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | -$14.35M | n/m |
| Vaso Corp (VASO) | 2025-12-31 | -$2.03M | n/m |
| Ceribell, Inc. (CBLL) | 2025-12-31 | -$57.06M | n/m |
Compare MDT, ITGR, TMDX, INMD side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗